PCT No. PCT/JP95/00736 Sec. 371 Date Oct. 9, 1996 Sec. 102(e) Date Oct. 9, 1996 PCT Filed Apr. 14, 1995 PCT Pub. No. WO95/28177 PCT Pub. Date Oct. 26, 1995A method for therapeutically treating tardive dyskinesia, which comprises a compound having an enzyme-inhibitory activity against a phospho-diesterase as the active ingredient, is now provided. Rolipram is preferred as the active ingredient. When rolipram is administered to such rats as experimental model, which have tardive dyskinesia induced by consecutive administrations of haloperidol, there can be obtained such curative effect that the symptoms of tardive dyskinesia are suppressed dose-dependently.
Method for therapeutically treating tardive dyskinesia and uses thereof